The Cancer Therapy &Research Center (CTRC) is led by Director, Ian M. Thompson, Jr., M.D. Dr. Thompson is assisted in this role by a Senior Leadership team, comprised of a Deputy Director and five Associate Directors, each of whom has expertise in their area of responsibility. They are: Tim H-M. Huang, Ph.D., Deputy Director;Karen Block, Ph.D., Associate Director for Shared Resources;Susan Padalecki, Ph.D., Associate Director for Research Administration;Amelie Ramirez, Dr. P.H., Associate Director for Cancer Prevention and Health Disparities;LuZhe Sun, Ph.D., Associate Director for Translational Research; and Steven Weitman, M.D., Ph.D., Associate Director for Clinical Research. The CTRC Senior Leadership team meets weekly with the Leaders of the CTRC Scientific Programs as an Executive Committee. One on one meetings with the Director and each other occur frequently as needed. Members of the Senior Leadership team provide counsel and recommendations to the Director based on these interactions and their interactions with the CTRC membership. Final authority for decisions on behalf of the CTRC resides with the Director. The Senior Leadership works directly with the Program Leaders, Shared Resource Directors, and other CTRC committees to build consensus on CTRC-wide priorities, strategies, and allocation of resources. The Senior Leaders ensure consistency in the mission, vision, and goals of the CTRC and develop synergistic interactions among the basic, translational, and clinical elements of the Center. They provide feedback on the growth and the needs of the CTRC in their area of responsibility. They also plan and implement proactive, integrative approaches for development of the research base, resources, and a formal strategic plan.
Support is requested for the Senior Leadership of the Cancer Therapy &Research Center (CTRC). This leadership is critical to ensuring the overall success of the CTRC in fulfilling its mission and meeting its goals and in the strategic planning and evaluation of all CTRC efforts.
|Ghosh, Sagar; Hughes, Daniel; Parma, Dorothy Long et al. (2014) Association of obesity and circulating adipose stromal cells among breast cancer survivors. Mol Biol Rep 41:2907-16|
|Meng, Jia; Lu, Zhiliang; Liu, Hui et al. (2014) A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package. Methods 69:274-81|
|Gong, Jingjing; Muñoz, Amanda R; Chan, Daniel et al. (2014) STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth. Oncotarget 5:2529-41|
|Fok, Wilson C; Livi, Carolina; Bokov, Alex et al. (2014) Short-term rapamycin treatment in mice has few effects on the transcriptome of white adipose tissue compared to dietary restriction. Mech Ageing Dev 140:23-9|
|Morales, Liza D; Casillas Pavón, Edgar A; Shin, Jun Wan et al. (2014) Protein tyrosine phosphatases PTP-1B, SHP-2, and PTEN facilitate Rb/E2F-associated apoptotic signaling. PLoS One 9:e97104|
|Mousavi, Seyed Mohsen; Sundquist, Jan; Hemminki, Kari (2014) Risk of Kaposi sarcoma among immigrants to Sweden. Acta Derm Venereol 94:476-7|
|Ankerst, Donna P; Boeck, Andreas; Freedland, Stephen J et al. (2014) Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol 32:185-91|
|Biswas, Tanuka; Gu, Xiang; Yang, Junhua et al. (2014) Attenuation of TGF-* signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model. Cancer Lett 346:129-38|
|Ramirez, Amelie G; Munoz, Edgar; Holden, Alan E C et al. (2014) Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update. PLoS One 9:e99365|
|Bansal, H; Yihua, Q; Iyer, S P et al. (2014) WTAP is a novel oncogenic protein in acute myeloid leukemia. Leukemia 28:1171-4|
Showing the most recent 10 out of 616 publications